{"adaptation_status":"machine_translated","adaptation_year":2026,"adapted":false,"age_range":"Дорослі віком від 18 років; українська адаптація, локальні норми, PASS/MCID thresholds або treatment decision rules не включені","catalog_art_image_url":null,"catalog_art_thumb_url":null,"catalog_language":"uk","categories":["Здоров'я","Клінічна психологія","Дослідницькі методи"],"category":"Здоров'я","content_warning":null,"cronbach_alpha":null,"empirical_duration_stats":null,"estimated_duration_minutes":6.6,"estimated_duration_range_minutes":[5,9],"estimated_duration_seconds":396.0,"family_label":"PsAID","fully_reviewed":false,"has_local_pdf":false,"has_original_pdf":false,"in_progress_invite_token":null,"in_progress_last_activity_at":null,"instructions":"Будь ласка, вкажіть, наскільки ваш псоріатичний артрит впливав на вас. Відповідайте на основі того, як ви почувалися протягом останнього тижня.","instructions_f":null,"instructions_m":null,"interpretation_band_count":0,"interpretation_bands":[],"is_favorite":false,"item_count":12,"item_prompt":"Протягом останнього тижня:","item_prompt_f":null,"item_prompt_m":null,"latest_result":null,"norm_count":1,"norms":[{"age_range":"Adults with psoriatic arthritis","label":"Контекст джерельного скорингу PhenX PX172001 / EULAR PsAID-12","mean_total":null,"modeled_score_norms":false,"note":"PhenX PX172001 provides the English PsAID-12 source form, 0-10 NRS response route, weighted score formula, source missing-data rule, and EULAR PsAID attribution. This is source scoring context only, not a norm sample, clinical threshold, disease-activity reference, Ukrainian validation, or Ukrainian norm comparison.","sample_size":"protocol record","sd_total":null,"source_citation":"PhenX Toolkit. Psoriatic Arthritis (PsA) - Impact of Disease, protocol 172001. https://www.phenxtoolkit.org/protocols/view/172001","source_url":"https://www.phenxtoolkit.org/protocols/view/172001"}],"options":[{"label":"0 - Немає","label_f":null,"label_m":null,"value":0},{"label":"1","label_f":null,"label_m":null,"value":1},{"label":"2","label_f":null,"label_m":null,"value":2},{"label":"3","label_f":null,"label_m":null,"value":3},{"label":"4","label_f":null,"label_m":null,"value":4},{"label":"5","label_f":null,"label_m":null,"value":5},{"label":"6","label_f":null,"label_m":null,"value":6},{"label":"7","label_f":null,"label_m":null,"value":7},{"label":"8","label_f":null,"label_m":null,"value":8},{"label":"9","label_f":null,"label_m":null,"value":9},{"label":"10 - Надзвичайно","label_f":null,"label_m":null,"value":10}],"original_pdf_url":null,"original_source_citation":"Gossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., Maccarone, M., Carton, L., Otsa, K., Sooaar, I., Heiberg, T., Bertheussen, H., Canete, J. D., Sanchez Lombarte, A., Balanescu, A., Dinte, A., de Vlam, K., Smolen, J. S., Stamm, T., Niedermayer, D., Bekes, G., Veale, D., Helliwell, P., Parkinson, A., Luger, T., & Kvien, T. K.; EULAR PsAID Taskforce. (2014). A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Annals of the Rheumatic Diseases, 73(6), 1012-1019. https://doi.org/10.1136/annrheumdis-2014-205207","original_source_url":"https://ard.bmj.com/content/73/6/1012","original_year":2014,"pdf_url":null,"pool_count":0,"questions":[{"counts_toward_total":true,"id":"q1","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.15,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.15,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує біль, який ви відчували через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q2","options":[{"label":"0 - Немає втоми","label_f":null,"label_m":null,"value":0},{"label":"1","label_f":null,"label_m":null,"value":1},{"label":"2","label_f":null,"label_m":null,"value":2},{"label":"3","label_f":null,"label_m":null,"value":3},{"label":"4","label_f":null,"label_m":null,"value":4},{"label":"5","label_f":null,"label_m":null,"value":5},{"label":"6","label_f":null,"label_m":null,"value":6},{"label":"7","label_f":null,"label_m":null,"value":7},{"label":"8","label_f":null,"label_m":null,"value":8},{"label":"9","label_f":null,"label_m":null,"value":9},{"label":"10 - Повністю виснажений/виснажена","label_f":null,"label_m":null,"value":10}],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує загальний рівень втоми через псоріатичний артрит, який ви відчували протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q3","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує шкірні проблеми, зокрема свербіж, які ви відчували через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q4","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує труднощі повноцінної участі в роботі та/або дозвіллі через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q5","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує труднощі у виконанні щоденних фізичних активностей через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q6","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує відчуття дискомфорту й роздратування через повсякденні завдання, пов'язані з псоріатичним артритом, протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q7","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.1,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.1,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує труднощі зі сном, тобто нічним відпочинком, які ви відчували через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q8","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.05,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.05,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Якщо розглядати ваш псоріатичний артрит загалом, наскільки добре ви справлялися, керували ситуацією або давали собі раду з ним протягом останнього тижня?","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q9","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.05,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.05,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує рівень тривоги, страху та невизначеності, наприклад щодо майбутнього, лікування або страху самотності, через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q10","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.05,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.05,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Якщо розглядати ваш псоріатичний артрит загалом, оберіть число, яке найкраще описує рівень збентеження та/або сорому через зовнішній вигляд, який ви переживали протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q11","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.05,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.05,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує труднощі повноцінної участі в соціальних активностях, зокрема у стосунках із родиною та/або дуже близькими людьми, через псоріатичний артрит протягом останнього тижня.","text_f":null,"text_m":null},{"counts_toward_total":true,"id":"q12","options":[],"reverse":false,"scale_contributions":[{"coefficient":1,"kind":"scale","label":"Індекс впливу PsAID-12","question_count":12,"score_mode":"sum","score_multiplier":1,"slug":"psaid12-impact-score"},{"coefficient":0.05,"kind":"total","label":"Загальний бал","question_count":1,"score_mode":"sum","score_multiplier":0.05,"slug":"_total"}],"supplemental_kind":"","supplemental_label":"","supplemental_note":"","text":"Оберіть число, яке найкраще описує рівень пригніченості через псоріатичний артрит, який ви відчували протягом останнього тижня.","text_f":null,"text_m":null}],"ready_for_delivery":true,"related_catalog_versions":[{"adaptation_status":"unadapted","catalog_language":"en","href":"/catalog/psaid-12-psoriatic-arthritis-impact-en?language=en","label":"English version","ready_for_delivery":true,"slug":"psaid-12-psoriatic-arthritis-impact-en","title":"Psoriatic Arthritis Impact of Disease (PsAID-12)"}],"response_scale":"Дванадцять пунктів із числовою рейтинговою шкалою 0-10; джерельний зважений бал PsAID-12 має діапазон 0-10, де вищі бали означають гірший вплив","scale_choices":[],"scale_count":1,"scale_labels":["Індекс впливу PsAID-12"],"scale_norm_samples":[],"scales":[{"description":"Джерельний зважений загальний бал PsAID-12. Вищі бали означають більший самооцінений вплив псоріатичного артриту.","interpretation_bands":[],"label":"Індекс впливу PsAID-12","norm_mean":null,"norm_sd":null,"question_ids":["q1","q2","q3","q4","q5","q6","q7","q8","q9","q10","q11","q12"],"score_max":120,"score_min":0,"score_mode":"sum","score_multiplier":1.0,"score_norms":[],"score_range":{"max":120,"min":0,"possible_scores":[0,1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120],"step":1},"score_step":1,"scoring_note":"Джерельна формула PsAID-12 множить біль на 3; втому, шкірні проблеми, роботу/дозвілля, функціонування, дискомфорт і сон на 2; а подолання, тривогу/страх/невизначеність, збентеження/сором, соціальну участь і пригніченість на 1; після цього зважену суму ділять на 20. Якщо пропущено один NRS-пункт, використовується середнє інших 11 NRS-значень; якщо пропущено два або більше, бал PsAID не повідомляється.","slug":"psaid12-impact-score"}],"score_norms":[],"score_range":{"max":10,"min":0,"possible_scores":[0,0.05,0.1,0.15,0.2,0.25,0.3,0.35,0.4,0.45,0.5,0.55,0.6,0.65,0.7,0.75,0.8,0.85,0.9,0.95,1,1.05,1.1,1.15,1.2,1.25,1.3,1.35,1.4,1.45,1.5,1.55,1.6,1.65,1.7,1.75,1.8,1.85,1.9,1.95,2,2.05,2.1,2.15,2.2,2.25,2.3,2.35,2.4,2.45,2.5,2.55,2.6,2.65,2.7,2.75,2.8,2.85,2.9,2.95,3,3.05,3.1,3.15,3.2,3.25,3.3,3.35,3.4,3.45,3.5,3.55,3.6,3.65,3.7,3.75,3.8,3.85,3.9,3.95,4,4.05,4.1,4.15,4.2,4.25,4.3,4.35,4.4,4.45,4.5,4.55,4.6,4.65,4.7,4.75,4.8,4.85,4.9,4.95,5,5.05,5.1,5.15,5.2,5.25,5.3,5.35,5.4,5.45,5.5,5.55,5.6,5.65,5.7,5.75,5.8,5.85,5.9,5.95,6,6.05,6.1,6.15,6.2,6.25,6.3,6.35,6.4,6.45,6.5,6.55,6.6,6.65,6.7,6.75,6.8,6.85,6.9,6.95,7,7.05,7.1,7.15,7.2,7.25,7.3,7.35,7.4,7.45,7.5,7.55,7.6,7.65,7.7,7.75,7.8,7.85,7.9,7.95,8,8.05,8.1,8.15,8.2,8.25,8.3,8.35,8.4,8.45,8.5,8.55,8.6,8.65,8.7,8.75,8.8,8.85,8.9,8.95,9,9.05,9.1,9.15,9.2,9.25,9.3,9.35,9.4,9.45,9.5,9.55,9.6,9.65,9.7,9.75,9.8,9.85,9.9,9.95,10],"step":0.05},"scoring_note":"PsyMeasure calculates the source PsAID-12 impact score by multiplying pain by 3; fatigue, skin, work/leisure, function, discomfort, and sleep by 2 each; coping, anxiety/fear/uncertainty, embarrassment/shame, social participation, and depression by 1 each; then dividing the weighted sum by 20. The score range is 0-10, where higher scores indicate worse patient-reported impact. The scoring hook mirrors the source missing-data rule: one missing NRS item can be imputed from the mean of the other 11; two or more missing NRS items produce no PsAID total. No PASS threshold, MCID, disease-activity category, diagnostic threshold, treatment rule, norm, validation statistic, interpretation band, official Ukrainian translation, Ukrainian validation, or Ukrainian comparison row is encoded.","search_terms":["Gossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., Maccarone, M., Carton, L., Otsa, K., Sooaar, I., Heiberg, T., Bertheussen, H., Canete, J. D., Sanchez Lombarte, A., Balanescu, A., Dinte, A., de Vlam, K., Smolen, J. S., Stamm, T., Niedermayer, D., Bekes, G., Veale, D., Helliwell, P., Parkinson, A., Luger, T., & Kvien, T. K.; EULAR PsAID Taskforce. (2014). A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: Elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Annals of the Rheumatic Diseases, 73(6), 1012-1019. https://doi.org/10.1136/annrheumdis-2014-205207","PsyMeasure machine translation (2026) of PhenX protocol 172001, Psoriatic Arthritis Impact of Disease (PsAID-12).","psaid12 impact score"],"slug":"psaid-12-psoriatic-arthritis-impact-uk-ai","source_citation":"PsyMeasure machine translation (2026) of PhenX protocol 172001, Psoriatic Arthritis Impact of Disease (PsAID-12).","source_url":"https://www.phenxtoolkit.org/protocols/view/172001","special_use_notice":"Машинний переклад PsyMeasure з PhenX/ePROVIDE/EULAR PsAID-12 route. PsAID-12 is an adult patient-reported impact-of-disease measure for psoriatic arthritis, not a diagnosis, disease-activity classifier, screening test, medication or biologic eligibility tool, treatment recommendation, emergency triage, disability/legal determination, depression/anxiety diagnostic measure, Ukrainian validated adaptation, cutoff, or Ukrainian norm comparison. Severe or worsening pain, functional decline, sleep disruption, skin complications, distress, depression, anxiety, medication concerns, or urgent clinical changes should be reviewed with qualified medical care.","status_note":"Українська форма `psaid-12-psoriatic-arthritis-impact-uk-ai` є машинним перекладом PsyMeasure з англомовного маршруту `psaid-12-psoriatic-arthritis-impact-en`. Source route: PhenX protocol 172001 (https://www.phenxtoolkit.org/protocols/view/172001), PhenX PDF (https://www.phenxtoolkit.org/toolkit_content/PDF/PX172001.pdf), ePROVIDE public-domain PsAID-12 record (https://eprovide.mapi-trust.org/instruments/psoriatic-arthritis-impact-of-disease), and EULAR PsAID context (https://www.eular.org/eular-tools-and-products). PsyMeasure preserves 12 item IDs, 0-10 NRS response values, the source weighted score formula, one-missing-item imputation rule, 0-10 score range, and higher-is-worse scoring direction. This is not a reviewed Ukrainian adaptation, official Ukrainian translation, Ukrainian validation, Ukrainian norm row, PASS threshold, MCID, disease-activity category, diagnostic threshold, treatment rule, medication or biologic eligibility tool, emergency triage route, disability/legal determination, cutoff, percentile, T-score, interpretation-band route, or validated Ukrainian form.","summary":"Машинно перекладена українська форма PsAID-12 для самооцінки впливу псоріатичного артриту за останній тиждень. PsyMeasure reports the source weighted 0-10 impact score only, without diagnosis, disease-activity classification, treatment advice, Ukrainian validation, or Ukrainian norms.","target_group":"Україномовні дорослі з псоріатичним артритом у ревматологічних, клінічно-практичних, health-outcomes або дослідницьких контекстах; машинний переклад потребує людської та медичної перевірки","tier":0,"title":"Вплив псоріатичного артриту (PsAID-12) - машинний переклад","typical_duration_minutes":4.0,"variants":["psaid-12-psoriatic-arthritis-impact-en"],"year":2026}